About Cabaletta Bio Cabaletta Bio (Nasdaq: CABA) is a late-stage clinical biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for ...
Calico Life Sciences LLC (Calico), a clinical-stage biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, Ph.D., today announced the ...
Experienced biotech executive brings more than 20 years of leadership experience in company creation, strategy, and drug development VectoryY Therapeutics, a leader in vectorized antibody therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results